#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15272	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2276	669.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1549	1549	C	887	C	831	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15272	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2276	669.2	0	HET	.	.	.	C207T	.	207	207	C	572	572	C	864	C,T	614,184	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15272	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2276	669.2	0	HET	.	.	.	C451T	.	451	451	C	816	816	C	876	C,T	413,410	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27748	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3633	761.9	0	.	n	.	0	T695C	SNP	695	695	T	1041	1041	C	904	C	823	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27748	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3633	761.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2317	2317	C	916	C	835	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27748	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3633	761.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2391	2391	A	927	A	878	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27748	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3633	761.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2943	2943	C	826	C	783	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27748	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3633	761.9	0	HET	.	.	.	A1638G	.	1638	1638	A	1984	1984	A	896	A,G	440,408	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	Q7R	NONSYN	19	21	CAG	370	372	CGG	154;156;157	C;G;G	138;141;141	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	F31L	NONSYN	91	93	TTT	442	444	TTA	138;140;141	T;T;A	129;130;128	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	S32P	NONSYN	94	96	TCC	445	447	CCC	141;139;137	C;C;C	128;128;126	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	.	INDELS	127	129	ACA	479	486	ACGCCCAA	151;148;148;149;149;152;151;150	A;C;G;C;C;C;A;A	142;139;138;140;140;142;140;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	508	510	CGG	155;157;157	C;G;G	147;149;148	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	S68P	NONSYN	202	204	TCG	562	564	CCG	151;153;149	C;C;G	141;142;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	P84S	NONSYN	250	252	CCT	610	612	TCT	147;147;146	T;C;T	136;135;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	I115V	NONSYN	343	345	ATC	703	705	GTC	189;191;195	G;T;C	175;167;179	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	L149V	NONSYN	445	447	TTG	805	807	GTG	226;221;223	G;T;G	204;197;202	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	I188T	NONSYN	562	564	ATA	922	924	ACA	190;188;189	A;C,G;A	176;173,1;173	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	F193_G194del	DEL	577	577	T	937	937	T	180	T	168	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	P200T	NONSYN	598	600	CCC	952	954	ACC	173;168;169	A,G;C;C	160,1;161;160	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1012	1014	TTG	171;169;165	T;T;G	166;164;160	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	S230G	NONSYN	688	690	AGC	1042	1044	GGC	173;172;174	G;G;C	167;164;165	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1820	folP	858	858	95.16	folP.l15.c4.ctg.1	1709	106.2	0	.	p	.	0	T231M	NONSYN	691	693	ACG	1045	1047	ATG	176;175;174	A;T;G,T	167;165;165,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5536	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3443	160.4	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	175;175;175	T;T;C	166;167;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5536	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3443	160.4	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	171;168;169	G;G;C	164;162;162	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5536	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3443	160.4	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	171;168;169	G;G;C	164;162;162	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1652	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1415	116.6	1	SNP	p	G45D	0	.	.	133	135	GGC	526	528	GGC	221;219;221	G;G;C	210;210;214	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	860	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1054	81.0	0	.	n	.	0	A197.	DEL	197	197	A	576	576	A	203	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6076	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2755	218.6	1	SNP	p	D86N	0	.	.	256	258	GAC	447	449	GAC	220;222;224	G;A;C	210;209;214	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6076	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2755	218.6	1	SNP	p	R87I	0	.	.	259	261	CGT	450	452	CGT	224;226;229	C,T;G;T	213,1;212;218	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6076	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2755	218.6	1	SNP	p	R87W	0	.	.	259	261	CGT	450	452	CGT	224;226;229	C,T;G;T	213,1;212;218	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6076	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2755	218.6	1	SNP	p	S87R	1	.	.	259	261	CGT	450	452	CGT	224;226;229	C,T;G;T	213,1;212;218	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6076	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2755	218.6	1	SNP	p	S88P	0	.	.	262	264	TCC	453	455	TCC	226;226;227	T;C;C	214;216;215	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4456	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2544	174.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1548	1550	GGC	218;215;211	G;G;C	198;195;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1201	1203	GCC	218;219;219	G;C;C	201;203;203	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1204	1206	ATG	217;221;224	A;T;G	206;209;210	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1216	1218	ACC	228;228;230	A;C;C	214;211;216	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1216	1218	ACC	228;228;230	A;C;C	214;211;216	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1717	1719	ACC	221;222;226	A;C;C	199;206;212	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1771	1773	GCG	214;215;214	G;C;G	194;199;197	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1771	1773	GCG	214;215;214	G;C;G	194;199;197	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1894	1896	GGT	193;191;189	G;G;T,C	173;172;166,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1903	1905	AGC	186;188;185	A,G;G;C	167,2;168;165	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2252	180.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1921	1923	CCG	160;168;167	C,G;C,G;G	117,7;122,1;128	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6160	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3066	200.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1618	1620	CCG	238;239;237	C;C;G	207;218;209	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2672	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1819	146.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	514	514	C	176	C	164	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2892	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1369	207.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	330	332	GTT	252;252;250	G;T;T	233;233;229	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2892	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1369	207.9	0	.	p	.	0	G321S	NONSYN	961	963	GGC	1158	1160	AGC	226;228;228	A;G,T;C	212;214,1;215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2892	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1369	207.9	1	SNP	p	G120K	1	.	.	358	360	AAG	555	557	AAG	233;235;237	A;A;G	222;222;219	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2892	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1369	207.9	1	SNP	p	A121N	1	.	.	361	363	AAC	558	560	AAC	239;237;234	A;A;C	222;223;219	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2892	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1369	207.9	1	SNP	p	N121D	0	.	.	361	363	AAC	558	560	AAC	239;237;234	A;A;C	222;223;219	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11030	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4851	226.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1106	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	979	111.9	1	SNP	p	V57M	1	.	.	169	171	ATG	458	460	ATG	227;226;224	A;T;G	213;211;210	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
